TMS Ep443: IPL revenue, data misuse, markets, Neuralink
Is the IPL India's Superbowl? Who protects the data you share while shopping? Do EMs stand to gain with a higher US debt ceiling? What is Neuralink? Answers here
Team TMS New Delhi
It had hit a boundary on the very first ball. The Indian Premier League (IPL) became the country’s first unicorn in 2008 -- the year it was formed. And in its 15th year, just before the beginning of this year’s season, it became a decacorn, with its business value crossing the $10 billion mark. IPL has indeed brought unprecedented windfall to cricket. Its huge popularity has brought lucrative media and sponsorship deals over the years. So in today’s first story we explore if the IPL has become what Super Bowl is in the USA?
Did unwanted messages irk you while you were enjoying the nail- biting IPL match? And do you also get annoying calls? Then you are not the only one who is complaining about it. An increased number of people are reporting about such unwanted calls and messages. And the government is working to address it. Last week, it asked retailers not to insist on phone numbers of customers. So what are the regulations around sharing of phone numbers? Which authority monitors it? And finally, how will the upcoming Digital Personal Data Protection Bill protect your data?
Talking about data, Meta was slapped with a record $1.3 billion privacy fine last week. The reason? It was accused of transferring data to the US agencies. Moving on, the US leaders reached a tentative deal to raise the government’s 31.4 trillion dollar debt ceiling for two years. This measure brought a relief rally in equity markets across the globe on Monday, May 29. Going ahead, will this uptrend sustain or fizzle out soon? Moreover, will the expanded US debt limit make emerging markets a favourable bet?
It is not just lifting of the debt ceiling. The US took another big decision last week which may also have far reaching consequences. The country’s Food and Drug Administration finally gave a nod to Elon Musk’s brain-implant startup Neuralink to go ahead with the first human clinical study. The company plans to use its microchips to treat conditions such as paralysis. Listen to this episode of the podcast for more.
IPL 2023: What happens if rain washes out today's CSK vs GT match too?
IPL 2023 FAQ pack: New, old, and everything one must know before season 16
IPL 2023 KKR vs RCB preview: Bullish Bangalore up against Kolkata at Eden
US debt ceiling: Why the government of the USA may go bankrupt soon?
TV viewership of first 29 IPL matches higher than entire tournament in 2022
TMS Ep442: New Parliament building, Mt Everest, Nilesh Shah, price rigging
TMSEp441: 9 yrs of Modi, EU's Meta fine, LIC stock, Sengol
TMSEp440: Chinese firms, political strategists, markets, sugar alternatives
TMS Ep439: Sebi's Adani probe, Delhi Metro, paint & tyre stocks, Hawala
TMS Ep438: Withdrawal of Rs 2,000 notes, bank stocks, clean note policy
First Published: May 30 2023 | 12:18 PM IST